Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Concordia Director sells 100,000 shares on Dec 29.
View:
Post by argentia77 on Jan 02, 2016 9:43am

Concordia Director sells 100,000 shares on Dec 29.

Director Jordan Kapinsky bought 103,217 shares on October 19, 2015 for between $51.80 and $52.87 and on December 29 he sold 100,000 shares for $57.80 for a net profit of at least $500,000.  Nice Christmas bonus!  link
Comment by argentia77 on Jan 02, 2016 10:02am
Jordan Kupinsky's business profilehttps://www.4-traders.com/business-leaders/Jordan-Kupinsky-082WZJ-E/biography/
Comment by argentia77 on Jan 02, 2016 10:27am
Correction: Kupinsky bought 103,217 common shares of CXR on November 19, 2015, not October 19.  He's Concordia's Lead Independent Director. Why would he do this now and not wait a week or 2 until after Investor Day? 
Comment by Scruggstyle on Jan 02, 2016 12:18pm
It looks like the majority of his shareholdings are held in a family trust and a partnership. We may never know why the shares were sold. How was the original purchase financed? Just something to keep an eye on, I guess.
Comment by ChartSchool on Jan 02, 2016 12:51pm
Scrugg and Argentia.  After doing a search on SEDI for Kupinsky, I noticed that the 2015-11-19 of 100,000 shares was not a purchse on the public market but was an exercise of options at $3.00USD.  (Probably awarded to him from the Mercari days.)  Because he exercised these options in November, Kupinsky would have had to report a taxable employment benefit in 2015, so he would ...more  
Comment by ChartSchool on Jan 02, 2016 1:03pm
Oops.... That should not read "$5 million Valeant shares", but should instead read "5 million Valeant shares."   I hope I got the amount right now!  If not, I'm sure someone will correct me. Chart
Comment by ShortAttack on Jan 03, 2016 4:03pm
This post has been removed in accordance with Community Policy
Comment by Azures on Jan 03, 2016 4:14pm
What "bad news" are you referring to? Please enlighten me.
Comment by argentia77 on Jan 03, 2016 5:09pm
Maybe this will put your mind at ease:  https://www.reddit.com/r/CXR/comments/3z57cb/insider_selling_concordia_healthcare_corp_cxr/
Comment by notwrong on Jan 03, 2016 5:58pm
This post has been removed in accordance with Community Policy
Comment by ShortAttack on Jan 03, 2016 7:00pm
This post has been removed in accordance with Community Policy
Comment by notwrong on Jan 03, 2016 8:07pm
This post has been removed in accordance with Community Policy
Comment by ShortAttack on Jan 03, 2016 9:11pm
This post has been removed in accordance with Community Policy
Comment by notwrong on Jan 03, 2016 9:19pm
This post has been removed in accordance with Community Policy
Comment by Bullphighter on Jan 02, 2016 10:47am
Ouch
Comment by notwrong on Jan 03, 2016 9:39am
This post has been removed in accordance with Community Policy
Comment by zone1 on Jan 03, 2016 2:10pm
Not wrong... You cannot be right. You are just too funny.  I do feel sorry for you and hope you can find some peace in the new year and give others some too. Lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities